ADVA
21.9.2021 09:02:50 CEST | Business Wire | Press release
ADVA (FSE: ADV) and SIA, Indra’s cybersecurity company, today announced that RedIRIS is deploying ADVA’s technology to create a robust, high-capacity research and education network (NREN). The new long-haul backbone infrastructure connects universities and research facilities across Spain, enabling educators and scientists to share huge data sets and harness bandwidth-intensive applications. Built on the ADVA FSP 3000 and monitored by the ADVA ALM fiber assurance solution, the network carries services at speeds up to 200Gbit/s. Featuring ADVA’s ROADM technology and QuadFlex™ line cards, the open solution has given RedIRIS an easy way to migrate from legacy technology to flexible, high-performance connectivity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005058/en/
“Our new transport system empowers Spain’s scientists and academics to work together on national and international projects under optimum conditions. With flexible coherent wavelengths up to 200Gbit/s, it provides secure, highly reliable access to everything from video conferencing tools to high-performance remote computing facilities,” said Esther Robles, head of communications networks, RedIRIS. “ADVA’s open FSP 3000 technology enabled a smooth and painless transition from our existing transport infrastructure. With its modular design, it also provides massive scale, giving us the freedom to easily expand and evolve our network to meet future needs.”
Connecting more than 80 points of presence and over 500 institutions, RedIRIS’s new backbone network includes long-haul single-span submarine links to Spain’s Balearic Islands and the city of Melilla, as well as connections to the Canary Islands, the Canarian Institute of Astrophysics and its observatories. For flexibility and high spectral efficiency, the solution features ADVA’s flexgrid multi-degree ROADMs, enabling high-speed coherent and high-baud-rate transport. Through ADVA’s MicroMux™ technology, the new infrastructure also supports a seamless mix of 10Gbit/s and 100Gbit/s Ethernet client ports without any footprint increase. This optimizes space efficiency and ensures no stranded bandwidth. The network upgrade also involved the deployment of a solid and thorough migration plan by SIA, a leading Indra company in cybersecurity and ADVA’s Select partner.
“RedIRIS’s long-haul infrastructure is now one of Europe’s most advanced NRENs. It will enable researchers and teachers in Spain to leverage a new breed of data-intensive applications and collaborate in new ways using innovative video conferencing and augmented reality tools,” commented Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “Our open and scalable technology efficiently bridges the gap between the legacy needs and the future demand of RedIRIS’s users. Its unique client port flexibility supports a mix of 10Gbit/s and 100Gbit/s Ethernet services without the need for additional hardware. With our open optical layer, RedIRIS is also free to tackle rising demands in the future by expanding to higher baud rates and more complex modulation schemes.”
“For the design and deployment of a complex project like this, it has been key to walk hand in hand with our client RedIRIS, to perfectly understand its requirements and choose the right professionals with the knowledge and capacity to migrate to a new network that meets the organization’s present and future needs for a wide range of services. The project allows RedIRIS to carry encoded critical services that assure a greater level of cybersecurity with no latency,” stated Alejandro Díez, director, digital risk, SIA. “This deployment gives RedIRIS’s users in the research and scientific community an extremely powerful tool for high-quality collaboration and global connectivity. It also prepares Spain’s NREN for the key challenges of the future as it looks to connect more schools, universities, research centers, global libraries, smart cities and IoT. RedIRIS will operate as a critical infrastructure and will assure an immediate communication service with any other geographic point of the network, with robust processes and higher cybersecurity.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
About Indra
Indra is one of the leading global technology and consulting companies and the technological partner for core business operations of its customers world-wide. It is a world-leader in providing proprietary solutions in specific segments in Transport and Defense markets, and a leading firm in Digital Transformation and Information Technologies in Spain and Latin America through its affiliate Minsait. Its business model is based on a comprehensive range of proprietary products, with a high-value focus and with a high innovation component. In the 2020 financial year, Indra achieved revenue of €3.043 billion, near 48,000 employees, a local presence in 46 countries and business operations in over 140 countries. www.indracompany.com
About SIA
SIA is the Indra company leading the cybersecurity sector in Spain and Portugal, both in terms of turnover and expert talent, with more than 1,200 specialists. Its value proposition is based on the specific responses it offers organizations to meet the challenges and threats posed by the four forces of digitalization: regulatory pressure, connected infrastructures, the transformation of IT architectures and the growing digital interaction of people; responses articulated through a set of specific measures and plans to minimize risk and maximize the protection of their businesses. Being a member of the Indra Group, one of the leading global technology and consultancy companies with business operations in 140 countries, provides SIA with a profound knowledge of the industries as well as a solid worldwide presence. Further information at www.sia.es .
About RedIRIS
RedIRIS is the Spanish academic and research network that provides advanced communication services to the scientific community and national universities. It is funded by the Ministry of Science and Innovation and is included in the Ministry’s map of Special Scientific and Technological Facilities (ICTS). It is managed by the Public Corporate Entity Red.es, which reports to the Ministry of Economic Affairs and Digital Transformation. RedIRIS has over 500 affiliated institutions, mainly universities and public research centres, which join this community by signing an affiliation agreement. www.rediris.es
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005058/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom